PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
51.07%
Positive revenue growth while JHX is negative. John Neff might see a notable competitive edge here.
119.16%
Positive gross profit growth while JHX is negative. John Neff would see a clear operational edge over the competitor.
-100.00%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
10650.00%
Positive operating income growth while JHX is negative. John Neff might view this as a competitive edge in operations.
1503.19%
Positive net income growth while JHX is negative. John Neff might see a big relative performance advantage.
1400.00%
Positive EPS growth while JHX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
1393.33%
Positive diluted EPS growth while JHX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.28%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
0.15%
Slight or no buyback while JHX is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
318.04%
OCF growth above 1.5x JHX's 0.26%. David Dodd would confirm a clear edge in underlying cash generation.
151.80%
FCF growth above 1.5x JHX's 70.83%. David Dodd would verify if the firm’s strategic investments yield superior returns.
30.07%
10Y revenue/share CAGR under 50% of JHX's 125.31%. Michael Burry would suspect a lasting competitive disadvantage.
92.82%
5Y revenue/share CAGR above 1.5x JHX's 49.44%. David Dodd would look for consistent product or market expansions fueling outperformance.
-22.83%
Negative 3Y CAGR while JHX stands at 9.81%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
1279.14%
10Y OCF/share CAGR at 50-75% of JHX's 2303.16%. Martin Whitman might fear a structural deficiency in operational efficiency.
241.68%
5Y OCF/share CAGR above 1.5x JHX's 64.86%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
408.16%
3Y OCF/share CAGR above 1.5x JHX's 6.68%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
3324.04%
Positive 10Y CAGR while JHX is negative. John Neff might see a substantial advantage in bottom-line trajectory.
655.30%
Positive 5Y CAGR while JHX is negative. John Neff might view this as a strong mid-term relative advantage.
-28.57%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
113.09%
Below 50% of JHX's 811.08%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
41.01%
Below 50% of JHX's 95.28%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
21.85%
Below 50% of JHX's 54.39%. Michael Burry suspects a serious short-term disadvantage in building book value.
153.74%
Stable or rising dividend while JHX is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
20.57%
Stable or rising mid-term dividends while JHX is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
-18.96%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
26.24%
Our AR growth while JHX is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
1.83%
Inventory growth well above JHX's 1.00%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.97%
Asset growth above 1.5x JHX's 0.92%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.99%
BV/share growth above 1.5x JHX's 2.60%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.96%
Debt growth far above JHX's 1.76%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
15.66%
SG&A growth well above JHX's 0.16%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.